<DOC>
	<DOCNO>NCT00753168</DOCNO>
	<brief_summary>The purpose study evaluate safety potential efficacy new drug , OT-730 ophthalmic solution ( eye drop ) , reduce intraocular pressure eye patient open angle glaucoma ocular hypertension . It compare commercial timolol placebo eye drop .</brief_summary>
	<brief_title>Phase 1-2 Evaluation OT-730 Eye Drops Reducing Intraocular Pressure Patients With Ocular Hypertension Open-Angle Glaucoma</brief_title>
	<detailed_description>Glaucoma group diseases eye result irreversible vision loss due damage optic nerve . Elevated intraocular pressure ( IOP ) one factor associate glaucoma . Currently-available medication use low IOP include beta-blocking agent , undesirable side effect cardiac respiratory system . The OT-730 ophthalmic solution contain OT-730 , prodrug , apply eyedrop , metabolize OT-705 , active beta blocker . The OT-730 ophthalmic solution study see well lower IOP patient diagnosis open angle glaucoma ocular hypertension . It compare well know beta blocker , timolol maleate ophthalmic solution , placebo eye drop , order ass ability low IOP without typical side effect beta blocker .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>healthy subject , 18 80 year age , gender diagnosis primary open angle , pseudoexfoliative pigmentary glaucoma ocular hypertension VA bad 20/200 , cataract compromise visualization fundus , history lack response ocular beta blocker therapy , uncontrolled intraocular pressure , angle closure glaucoma occludable angle , retinal detachment , macular hole , progressive vision loss , progressive retinal disease neurologic disease glaucoma likely worsen visual field acuity course study , history , current condition contraindicate use beta blocker ( e.g. , chronic obstructive pulmonary disease , bronchial asthma , congestive heart failure , myasthenia gravis , hypoglycemia , bradycardia , etc ) , chronic use steroid , disease , opinion investigator , may put patient significant risk , take systemic beta blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>glaucoma , open angle , ocular hypertension , beta blocker , beta adrenergic , intraocular pressure</keyword>
</DOC>